Analysis of prognostic factors in diffuse large B-cell lymphoma associated with rheumatic diseases
Objective The risk of developing diffuse large B-cell lymphoma (DLBCL) is increased in many rheumatic diseases (RDs). It is possible that RD-associated DLBCL is a distinct subset within the category of ‘DLBCL’, exhibiting characteristic biological features and clinical behaviour. However, informatio...
Saved in:
| Main Authors: | Vadim Gorodetskiy, Natalya Probatova, Tatiana Obukhova, Vladimir Vasilyev |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-04-01
|
| Series: | Lupus Science and Medicine |
| Online Access: | https://lupus.bmj.com/content/8/1/e000561.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Peripheral T-Cell Lymphoma of the Submandibular Salivary Gland as an Unusual Manifestation of Richter’s Syndrome: A Case Report and Literature Review
by: Vadim R. Gorodetskiy, et al.
Published: (2017-01-01) -
Simultaneous Occurrence of Rosai–Dorfman Disease and Nodal Marginal Zone Lymphoma in a Patient with Sjögren’s Syndrome
by: Vadim R. Gorodetskiy, et al.
Published: (2018-01-01) -
Prognostic significance of AIF expression in diffuse large B-cell lymphoma
by: Vitaly A. Rosin, et al.
Published: (2025-01-01) -
Serum hepatitis B core antibody as the prognostic factor for diffuse large B-cell lymphoma
by: Yi Rong, et al.
Published: (2025-05-01) -
CLINICAL CHARACTERISTICS AND PROGNOSTIC FACTORS IN PRIMARY BREAST DIFFUSE LARGE B-CELL LYMPHOMA
by: guangliang Chen, et al.
Published: (2022-08-01)